Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic HUCMSC-Derived EVs for Stable Non-Facial Vitiligo
NCT06813027Phase 1Active, not recruiting
- Sponsor
- University of Jordan
- Start
- Jan 2023
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial in Vitiligo (2 arms), sponsored by University of Jordan. Primary endpoint: Safety at 6 months. Started Jan 2023; status: active, not recruiting.
02
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT06813027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06813027.